Collection

The Critical Role of Regulations in Pharmacovigilance

Submission status
Closed
This collection highlights the indispensable intersect between health regulations and the discipline of pharmacovigilance. The dilemmas faced by medicine regulators as they address new challenges, the manner by which patients are involved in decision making, and where areas of synergies can be found with health technology assessments are new topics of interest for pharmacovigilance.

Editors

  • Kenneth Y. Hartigan-Go Kenneth Y. Hartigan-Go  &

    Kenneth Y. Hartigan-Go

    Dr. Kenneth Hartigan-Go is a Senior Research fellow at Ateneo de Manila University School of Government and an adjunct faculty of the Asian Institute of Management. He is an Honorary Visiting Associate Professor of the NUS Saw Swee Hock School of Public Health. He sits as independent director for corporations involved with health care. He was previously Undersecretary of the Philippine Department of Health and Director General of the Food and Drug Administration. His interest lies in health systems governance, health security, health innovations, outcome research and pharmacovigilance.

  • Raymond Chua Swee Boon Raymond Chua Swee Boon

    Raymond Chua Swee Boon

    Assoc Prof (Dr) Raymond Chua is a Registered Public Health Specialist and is presently the Deputy Director-General of Health of Health Regulation in the Ministry of Health. He oversees the regulation of healthcare services and health digitalization in Singapore to safeguard public health, while enabling healthcare innovations. He is concurrently designated as Assistant Commissioner for Cybersecurity in Healthcare, to assist in enhancing cybersecurity policies relating to Critical Information Infrastructures and Medical Devices in Singapore.

Articles (4 in this collection)